Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Taking vitamin D and calcium supplements reduces the risk of hip fractures by about one sixth, but taking vitamin D alone does not, according to a new study from the Nuffield Department of Population Health (NDPH) at the University of Oxford.

None © Shutterstock

The research was led by Research Fellow Dr Pang Yao and Robert Clarke, Professor of Epidemiology and Public Health Medicine, at NDPH. The researchers combined findings from 11 observational studies of vitamin D blood levels and the associated risk of fracture with more than 39,000 participants, 6 trials of combined vitamin D and calcium treatment with more than 49,000 participants, and 11 trials of vitamin D supplements alone with 34,000 participants. The research has been published in JAMA Network Open.

The observational studies showed that low blood levels of vitamin D are associated with higher risks of fracture, but the trial results have been inconclusive. The trials of vitamin D plus calcium showed a small reduction in the risk of fractures. In people over the age of 80 years, and those living in institutions however, the effects were greater, with the risk of hip fracture lowered by almost one-third. While the trials of vitamin D alone did not show a reduction in the risk of fracture, these trials included some large studies of very high annual doses of vitamin D which increased the risk of fracture, and few of the trials tested doses of vitamin D high enough to raise the blood levels of vitamin D sufficiently to reduce the fracture risk.

Read more (University of Oxford)

Similar stories

Ethics in Mental Health Digital Innovations for Young People in Africa: Digital Campaign

This campaign was led by a team of 29 Early Career Researchers (ECRs) and a Young People's Advisory Group (YPAG) across five African countries. The young people wanted to share contextual and accessible information on digital mental health and ethical issues that are important to them.

Cancer Research UK to invest £11 million into cancer science in Oxford

A £11 million Cancer Research UK investment has been awarded to the University of Oxford and Oxford-based NHS to catalyse the translation of its world-leading cancer research for patient benefit.

Review highlights risk factors associated with violence in schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.